Who are Dunad's investors?

Dunad's investors include BGV, Alpha Wave Global, Epidarex Capital.

Where is Dunad headquartered?

Dunad is headquartered in Cambridge, GB.

Dunad

Cambridge, GB · Founded 2020 · 12 employees on LinkedIn · 3 known investors

Dunad Therapeutics is a biotech company developing oral small-molecule medicines using a covalent chemistry discovery platform to target neurodegenerative diseases such as ALS, Parkinson's disease, and FTD. Its programs aim to clear disease-driving proteins like toxic TDP43 to slow disease progression for patients and their families.

Biotech Deep Tech

Founders & leadership

Pearl HuangPresident & CEO

Stephen HuhnCMO

Investors · 3

BGV✓ verifiedSilicon Valley

Alpha Wave GlobalMiami

Epidarex CapitalBethesda · $2.5M – $6.3M

In the news

Resurrect Bio raises $8M to scale its plant disease resistance platform. Lario Therapeutics bags $2.4M to pioneer calcium channel therapies. Axol Bioscience acquires Newcells' ophthalmology portfolio.cambridgebiocapital.substack.com · Feb 2026

Dr. Pearl Huang Named CEO of Novartis-Backed Dunad Therapeutics (Updated) - BioSpacebiospace.com · Jun 2022

Novartis inks US-$1.3bn deal with Dunad Therapeutics - European Biotechnology Magazineeuropean-biotechnology.com · Nov 2021

Frequently asked questions

What does Dunad do?: Dunad Therapeutics is a biotech company developing oral small-molecule medicines using a covalent chemistry discovery platform to target neurodegenerative diseases such as ALS, Parkinson's disease, and FTD. Its programs aim to clear disease-driving proteins like toxic TDP43 to slow disease progression for patients and their families.
Who are Dunad's investors?: Dunad's investors include BGV, Alpha Wave Global, Epidarex Capital.
Where is Dunad headquartered?: Dunad is headquartered in Cambridge, GB.